BIT
REGN icon

BlackRock Institutional Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

BlackRock Institutional Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$748M Buy
2,037,231
+19,389
+1% +$7.37M 0.11% 187
2016
Q3 		$811M Buy
2,017,842
+7,547
+0.4% +$3.03M 0.13% 162
2016
Q2 		$702M Buy
2,010,295
+49,006
+2% +$18.9M 0.11% 177
2016
Q1 		$707M Buy
1,961,289
+13,215
+0.7% +$5.45M 0.12% 170
2015
Q4 		$1.06B Buy
1,948,074
+9,653
+0.5% +$5.23M 0.17% 114
2015
Q3 		$902M Buy
1,938,421
+5,335
+0.3% +$2.87M 0.16% 124
2015
Q2 		$986M Sell
1,933,086
-82,743
-4% -$40.4M 0.16% 127
2015
Q1 		$910M Buy
2,015,829
+28,849
+1% +$12.2M 0.14% 142
2014
Q4 		$815M Sell
1,986,980
-17,113
-0.9% -$6.73M 0.13% 164
2014
Q3 		$723M Sell
2,004,093
-92,116
-4% -$30.9M 0.12% 166
2014
Q2 		$592M Buy
2,096,209
+35,120
+2% +$10.4M 0.1% 208
2014
Q1 		$619M Sell
2,061,089
-17,068
-0.8% -$5.26M 0.11% 190
2013
Q4 		$572M Buy
2,078,157
+29,453
+1% +$8.47M 0.1% 201
2013
Q3 		$641M Buy
2,048,704
+6,718
+0.3% +$1.77M 0.12% 162
2013
Q2 		$459M Buy
+2,041,986
New +$476M 0.09% 218

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

BlackRock Institutional Trust's REGN Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Regeneron Pharmaceuticals (REGN) stake by 0.96% in Q4 2016, buying an estimated $7.37M and bringing the position to 2,037,231 shares worth $748M. The position accounts for 0.11% of the portfolio, ranked #187.

BlackRock Institutional Trust first reported a position in REGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.06B in Q4 2015. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

  • BlackRock Institutional Trust held 2,037,231 shares of Regeneron Pharmaceuticals worth $748M as of Q4 2016.
  • BlackRock Institutional Trust bought 19,389 Regeneron Pharmaceuticals shares in Q4 2016, an estimated $7.37M.
  • Regeneron Pharmaceuticals made up 0.11% of BlackRock Institutional Trust's portfolio in Q4 2016, its #187 holding.
  • BlackRock Institutional Trust first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Regeneron Pharmaceuticals position peaked at $1.06B in Q4 2015.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.